DAPSONE
Generic: DAPSONE GEL, 5%, DAPSONE
Encube EthicalsManufacturer
TOPICALRoute
DAPSONEActive Substance
2023-10-13Original Approval
DAPSONE is FDA application ANDA212383, sponsored by ENCUBE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-10-29
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: VioCrystallization
Class II2024-12-10
Dapsone Gel 7.5%, 90 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Viona PharmCrystallization
Class II2024-09-24
Dapsone Gel 7.5%, 60 gram pump, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: VioCrystallization
Class II2024-12-10
Dapsone Gel 7.5%, 60 g, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahemedabad, India, Distributed by: Viona PharCrystallization
Top Reported Reactions
1
OFF LABEL USE
1,253 reports
2
DRUG INEFFECTIVE
1,036 reports
3
METHAEMOGLOBINAEMIA
495 reports
4
FATIGUE
469 reports
5
PYREXIA
463 reports
6
NAUSEA
458 reports
7
DIARRHOEA
403 reports
8
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
399 reports
9
PNEUMONIA
384 reports
10
DYSPNOEA
375 reports